Inhibition of sphingosine kinase 1 enhances cytotoxicity, ceramide levels and ROS formation in liver cancer cells treated with selenite

Combined treatment with selenite and the spingosine kinase 1 inhibitor SK1-II induces cell death in liver cancer cells (Huh7) without affecting non-tumorigenic immortalized liver cells (MIHA).